Log in
Enquire now
‌

US Patent 10658077 Enclosed RFID tracking system for identifying medical articles

Patent 10658077 was granted and assigned to IntelliGaurd on May, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
IntelliGaurd
IntelliGaurd
Current Assignee
IntelliGaurd
IntelliGaurd
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10658077
Date of Patent
May 19, 2020
Patent Application Number
16188229
Date Filed
November 12, 2018
Patent Citations Received
‌
US Patent 11996189 Management of pharmacy kits
0
‌
US Patent 11907902 Management of pharmacy kits using multiple acceptance criteria for pharmacy kit segments
0
‌
US Patent 12087422 Identifying discrepancies between events from disparate systems
0
‌
US Patent 12008630 Cabinet electronic requisition system
0
‌
US Patent 11557393 Medication tracking
‌
US Patent 11017352 Management of pharmacy kits using multiple acceptance criteria for pharmacy kit segments
‌
US Patent 11664105 Identifying discrepancies between events from disparate systems
0
Patent Primary Examiner
‌
Ryan W Sherwin
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10658077 Enclosed RFID tracking system for identifying medical articles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.